Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 301–400 of 1,000
Saini, C., Ramesh, V., & Nath, I. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002639 · Cited by 77
“Such cells were reported to be functionally non regulatory/ suppressive [17,18].”
BackgroundResultInfluentialMolecular Determinants of Regulatory T Cell Development: The Essential Roles of Epigenetic Changes
Kitagawa, Y., Ohkura, N., & Sakaguchi, S. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00106 · Cited by 61
“Furthermore, both human and murine naïve CD4 T cells transiently express Foxp3, without acquiring suppressive function (Allan et al., 2007; Wang et al., 2007; Miyao et al., 2012).”
BackgroundInhibition of FOXP3/NFAT Interaction Enhances T Cell Function after TCR Stimulation
Lozano, T., Villanueva, L., Durántez, M., Gorraiz, M., Ruiz, M., Belsúe, V., Riezu-Boj, J. I., Hervás-Stubbs, S., Oyarzábal, J., Bandukwala, H., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402997 · Cited by 61
“T cells through TCR can activate a transient FOXP3 expression, which is strongly associated with hyporesponsiveness of T cells (8).”
BackgroundInfluentialBroady, R., Yu, J., & Levings, M. K. (2009) · Blood · doi:10.1182/blood-2009-04-214437 · Cited by 60
Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells
Jenks, J. A., Seki, S. M., Kanai, T., Huang, J. J., Morgan, A. A., Scalco, R. C., Nath, R., Bucayu, R., Wit, J. M., Al–Herz, W., et al. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.04.014 · Cited by 60
“Alternatively, the reduced FOXP3 naïve and increased memory FOXP3 phenotype could be associated with conventional T cell activity rather than suppressor Treg [29,30].”
BackgroundThe Evolving Role of mTOR Inhibition in Transplantation Tolerance
McMahon, G., Weir, M. R., Li, X. C., & Mandelbrot, D. A. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010040351 · Cited by 60
Sideras, K., Galjart, B., Vasaturo, A., Pedroza‐González, A., Biermann, K., Mancham, S., Nigg, A. L., Hansen, B. E., Stoop, H., Zhou, G., et al. (2018) · Journal of Surgical Oncology · doi:10.1002/jso.25091 · Cited by 60
“For example, FoxP3 can in humans, in contrast to mice, also be expressed by activated helper T-cells.(26,27) In addition, activation-induced FoxP3 in human Teffector cells does not suppress proliferation or cytokine production.”
BackgroundTaflin, C., Nochy, D., Hill, G. S., Frouget, T., Rioux-Leclercq, N. C., Verine, J., Bruneval, P., & Glotz, D. (2010) · Transplantation · doi:10.1097/tp.0b013e3181c3ca11 · Cited by 59
“Immunosuppressive memory Tregs are distinguished by a high level of FoxP3 expression (18, 19).”
BackgroundSeverity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release
Eastwood, D., Bird, C., Dilger, P., Hockley, J., Findlay, L., Poole, S., Thorpe, S. J., Wadhwa, M., Thorpe, R., & Stebbings, R. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12165 · Cited by 58
Regulatory T Cell Dysfunction in Autoimmune Diseases
Honing, D. Y., Luiten, R. M., & Matos, T. R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137171 · Cited by 70
“Furthermore, human T cells expressing FoxP3 exhibit similarities to conventional T cells (Tconvs), since activated Tconvs have the potential to express low levels of FoxP3 [78].”
BackgroundEffects of pollen and nasal glucocorticoid on FOXP3+, GATA‐3+ and T‐bet+ cells in allergic rhinitis
Malmhäll, C., Bossios, A., Pullerits, T., & Lötvall, J. O. (2007) · Allergy · doi:10.1111/j.1398-9995.2007.01420.x · Cited by 59
“Two recent in vitro studies have shown that transient expression of FOXP3 can be found in any human CD4 T cell after activation (27, 28).”
BackgroundBarnas, J. L., Simpson-Abelson, M. R., Brooks, S. P., Kelleher, R. J., & Bankert, R. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000896 · Cited by 62
“Attempts to explore this possibility were confounded by the fact that human T lymphocytes transiently express Foxp3 upon activation (34, 35).”
BackgroundPericardial effusion under nivolumab: case-reports and review of the literature
Saade, A., Mansuet‐Lupo, A., Arrondeau, J., Thibault, C., Mirabel, M., Goldwasser, F., Oudard, S. M., & Weiss, L. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0760-4 · Cited by 59
Mercer, F. K., & Unutmaz, D. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1599-3_4 · Cited by 61
Infectious tolerance: therapeutic potential
Kendal, A. R., & Waldmann, H. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.08.002 · Cited by 64
HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection
Kared, H., Lelièvre, J., Donkova-Petrini, V., Aouba, A., Melica, G., Balbo, M., Weiss, L., & Lévy, Y. (2008) · AIDS · doi:10.1097/qad.0b013e328319edc0 · Cited by 64
“Although FoxP3 is now widely used for the characterization of human Treg cells in healthy individuals [31] contrasting findings have been reported on the kinetics and functional effects of transient FoxP3 expression in activated human CD4+CD25- T cells [29, 32-34].”
Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
Nausch, N., Midzi, N., Mduluza, T., Maizels, R. M., & Mutapi, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016860 · Cited by 58
“functionally heterogeneous [41] and that transient expression of FOXP3 on activated T cells does not correlate with suppressive function [42].”
BackgroundKluger, M. A., Meyer, M. C., Nosko, A., Goerke, B., Luig, M., Wegscheid, C., Tiegs, G., Stahl, R. A. K., Panzer, U., & Steinmetz, O. M. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090880 · Cited by 61
Substrate stiffness enhances human regulatory T cell induction and metabolism
Shi, L., Lim, J. Y., & Kam, L. C. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2022.121928 · Cited by 54
Tracking Antigen-Specific T-Cells during Clinical Tolerance Induction in Humans
Aslam, A., Chan, H., Warrell, D. A., Misbah, S., & Ogg, G. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011028 · Cited by 55
Severson, C., & Hafler, D. A. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2009_12 · Cited by 62
CD8+ T suppressor cells and the ILT3 master switch
Vlad, G., Cortesini, R., & Suciu‐Foca, N. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.286 · Cited by 57
Yang, X. (2007) · Frontiers in bioscience · doi:10.2741/2775 · Cited by 56
“A most recent report showed that FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as FOXP3 is also expressed in activated nonsuppressive T cells, suggesting that expression of endogenous FOXP3, in humans, is not su…”
BackgroundCsillag, A., Boldogh, I. R., Pázmándi, K., Magyarics, Z., Gogolák, P., Sur, S., Rajnavölgyi, É., & Bácsi, A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803938 · Cited by 56
Vergati, M., Cereda, V., Madan, R. A., Gulley, J. L., Huen, N. Y. M., Rogers, C. J., Hance, K. W., Arlen, P. M., Schlom, J., & Tsang, K. Y. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0927-9 · Cited by 53
“Furthermore, CD127 was not used as a negative surface marker for Tregs, and not all FoxP3 ? T cells are functionally suppressive in humans [ 54 ].”
Antvorskov, J. C., Fundová, P., Buschard, K., & Funda, D. P. (2012) · Immunology · doi:10.1111/imm.12007 · Cited by 66
Zhang, H. H., Song, K., Rabin, R. L., Hill, B. J., Perfetto, S. P., Roederer, M., Douek, D. C., Siegel, R. M., & Farber, J. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904156 · Cited by 58
“FOXP3 is expressed generally, but transiently, after activation of human T cells (59), as well as in human regulatory T cells (Tregs) (60, 61).”
BackgroundT Regulatory Cells in Cord Blood—FOXP3 Demethylation as Reliable Quantitative Marker
Liu, J., Lluis, A., Illi, S., Layland, L. E., Olek, S., von Mutius, E., & Schaub, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013267 · Cited by 54
“However, transient FOXP3 mRNA was also observed in activated non-Tregs, most notably in conventional CD4+ T-cells upon activation [11–12].”
BackgroundBenito, M., García-Carmona, Y., Balsa, A., de Ayala, C. P., Cobo‐Ibáñez, T., Martín-Mola, E., & Miranda‐Carús, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900007 · Cited by 62
Pekiner, F. N., Aytuğar, E., Demirel, G. Y., & Borahan, M. O. (2011) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2011.01061.x · Cited by 55
Fusco, L., Avitabile, E., Armuzza, V., Orecchioni, M., Istif, A., Bedognetti, D., Ros, T. D., & Delogu, L. G. (2020) · Carbon · doi:10.1016/j.carbon.2020.01.003 · Cited by 55
Regulation of FoxP 3+ Regulatory T Cells and Th17 Cells by Retinoids
Kim, C. H. (2008) · Clinical and Developmental Immunology · doi:10.1155/2008/416910 · Cited by 61
Potential Applications and Perspectives of Humanized Mouse Models
Ye, W., & Chen, Q. (2021) · Annual Review of Animal Biosciences · doi:10.1146/annurev-animal-020420-033029 · Cited by 64
Piper, K. P., Karanth, M., McLarnon, A., Kalk, E., Khan, N., Murray, J., Pratt, G., & Moss, P. A. H. (2011) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2011.04466.x · Cited by 54
Nunzio, S. D., Cecconi, M., Passerini, L., McMurchy, A. N., Baron, U., Türbachova, I., Vignola, S., Valencic, E., Tommasini, A., Junker, A., et al. (2009) · Blood · doi:10.1182/blood-2009-04-214593 · Cited by 54
Functional dynamics of Foxp3+ regulatory T cells in mice and humans
Dhuban, K. B., Kornete, M., Mason, E. S., & Piccirillo, C. A. (2014) · Immunological Reviews · doi:10.1111/imr.12168 · Cited by 60
Interleukin 4 promotes the development of ex-Foxp3 Th2 cells during immunity to intestinal helminths
Pelly, V. S., Coomes, S. M., Kannan, Y., Gialitakis, M., Entwistle, L. J., Perez-Lloret, J., Czieso, S., Okoye, I., Rückerl, D., Allen, J. E., et al. (2017) · The Journal of Experimental Medicine · doi:10.1084/jem.20161104 · Cited by 60
“It has previously been reported that activation of human T cells can lead to the transient expression of Foxp3 (Wang et al., 2007).”
BackgroundPre and probiotics in the prevention and treatment of food allergy
Savilahti, E., Kuitunen, M., & Vaarala, O. (2008) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e3282ffb134 · Cited by 52
Li, C., Ebert, P. J. R., & Li, Q.-J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.453357 · Cited by 59
“In line with this possibility, it is noteworthy that human naïve T cells transiently express Foxp3 during priming, even when their eventual fate is an effectorTh lineage (52, 53).”
BackgroundImproving the Efficacy of Regulatory T Cell Therapy
Baeten, P., Zeebroeck, L. V., Kleinewietfeld, M., Hellings, N., & Broux, B. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08866-1 · Cited by 55
Buckner, J. H., & Ziegler, S. F. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.014 · Cited by 52
Rojas, C., Campos‐Mora, M., Cárcamo, I., Villalón, N., Elhusseiny, A., Contreras‐Kallens, P., Refisch, A., Gálvez‐Jirón, F., Emparán, I., Montoya-Riveros, A., et al. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mr0420-533rr · Cited by 56
Functional stability of Foxp3+ regulatory T cells
Martins, M. D. S., & Piccirillo, C. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.06.001 · Cited by 58
Dexamethasone upregulates FOXP3 expression without increasing regulatory activity
Prado, C., Gómez, J. M. F., López, P., de Paz, B., Gutiérrez, C., & Suárez, A. (2010) · Immunobiology · doi:10.1016/j.imbio.2010.06.013 · Cited by 51
Memarian, A., Nourizadeh, M., Masoumi, F., Tabrizi, M. H., Emami, A. H., Alimoghaddam, K., Hadjati, J., Mirahmadian, M., & Jeddi‐Tehrani, M. (2012) · Tumor Biology · doi:10.1007/s13277-012-0578-x · Cited by 51
Cappellano, G., Ploner, C., Lobenwein, S., Sopper, S., Hörtnagl, P., Mayerl, C., Wick, N., Pierer, G., Wick, G., & Wolfram, D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192108 · Cited by 53
Lim, W. C., Olding, M., Healy, E., & Millar, T. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00565 · Cited by 50
“Although ECs increased FOXP3 expression within the previously CD25 −ve FOXP3 −ve population, the temporal nature of the FOXP3 expressing population suggests that these cells are likely to represent activated effector T cells which can express FOXP3 without acquiring a regulatory phenotype (21).”
BackgroundIsolation of human antigen‐specific regulatory T cells with high suppressive function
Noyan, F., Lee, Y., Zimmermann, K., Hardtke‐Wolenski, M., Taubert, R., Warnecke, G., Knoefel, A.-K., Schulde, E., Olek, S., Manns, M. P., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344381 · Cited by 52
Muratori, L., & Longhi, M. S. (2013) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.06.016 · Cited by 53
McMurchy, A. N., Gillies, J. K., Allan, S., Passerini, L., Gambineri, E., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.001 · Cited by 50
Chakraborty, S., Panda, A. K., Bose, S., Roy, D., Kajal, K., Guha, D., & Sa, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-01788-z · Cited by 52
Weissler, K. A., Rasooly, M. M., DiMaggio, T., Bolan, H., Cantave, D., Martino, D., Neeland, M. R., Tang, M. L. K., Dang, T. D., Allen, K. J., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.01.035 · Cited by 54
“Examination of ps-Treg cells Although expression of FOXP3 by the CD137(1) population supports the identification of these cells as Treg cells, human effector T cells can also upregulate FOXP3 after stimulation.(29) To confirm that the CD137(1) cells were bona fide Treg cells, we sorted both CD154(1) (ps-Teff) and CD13…”
Gilbert, R. M., Zhang, X., Sampson, R. D., Ehrenstein, M. R., Nguyen, D. X., Chaudhry, M., Mein, C. A., Mahmud, N., GALATOWICZ, G. E., Tomkins‐Netzer, O., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00907 · Cited by 53
“Asian/Middle Eastern 4 (40) 3 (23) 10 (27)”
Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcoma
Withers, S. S., Skorupski, K. A., York, D. S., Choi, J. W., Woolard, K., Amorim, R. L., Sparger, E. E., Rodriguez, C. O., McSorley, S. J., Monjazeb, A. M., et al. (2018) · Veterinary and Comparative Oncology · doi:10.1111/vco.12444 · Cited by 57
Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation
Vlad, G., Ho, E. K., Vasilescu, E. R., Fan, J., Liu, Z., Cai, J. W., Jin, Z., Burke, E. M., Deng, M. C.-H. K., Cadeiras, M., et al. (2007) · Transplant Immunology · doi:10.1016/j.trim.2007.03.001 · Cited by 56
“The controversy emerges primarily from the finding that in human CD25, FOXP3 and CTLA-4 are markers which are shared by Treg with a stable phenotype and by ‘transient’ regulatory T cells which represent only a stage in the differentiation of activated T cells (36, 37).”
Patients with posttraumatic stress disorder exhibit an altered phenotype of regulatory T cells
Jergović, M., Bendelja, K., Vidović, A., Savić, A., Vojvoda, V., Aberle, N., Rabatić, S., Jovanovic, T., & Sabioncello, A. (2014) · Allergy, Asthma & Clinical Immunology · doi:10.1186/1710-1492-10-43 · Cited by 49
“T cells that do not have regulatory properties [42].”
BackgroundMizuno, T., Suzuki, R., Umeki, S., & Okuda, M. (2009) · Journal of Veterinary Medical Science · doi:10.1292/jvms.001561 · Cited by 49
“Results from human studies showed that this is not uncommon since the expression of CD25 and Foxp3 has been shown to be upregulated after CD3/CD28 stimulation in CD4+CD25+ Foxp3+Treg populations [1, 17].”
BackgroundAbdulahad, W. H., Boots, A. M. H., & Kallenberg, C. G. M. (2010) · Rheumatology · doi:10.1093/rheumatology/keq328 · Cited by 54
Bikker, A., van Vliet-Moret, F. M., Kruize, A. A., Bijlsma, J. W. J., Lafeber, F. P. J. G., & van Roon, J. A. G. (2012) · Rheumatology · doi:10.1093/rheumatology/ker448 · Cited by 52
Kuczma, M., Podolsky, R. H., Garge, N. R., Daniely, D., Pacholczyk, R., Ignatowicz, L., & Kraj, P. J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800601 · Cited by 50
“Since conventional human CD4 T cells transiently up-regulate Foxp3 upon activation, it was not possible to determine the developmental origin of these cells (23).”
BackgroundUkena, S. N., Grosse, J., Weissinger, E. M., Buchholz, S., Stadler, M., Ganser, A., & Franzke, A. (2010) · Annals of Hematology · doi:10.1007/s00277-010-1068-0 · Cited by 51
“[ 14 ]. However, expression of IL-7Rα (CD127) has been established as a useful marker for discriminating CD4 + CD25 + Treg cells from activated T cells [15].”
Forkhead transcription factors in chronic inflammation
Peng, S. L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.013 · Cited by 49
Defining Human Regulatory T Cells beyond FOXP3: The Need to Combine Phenotype with Function
Gootjes, C., Zwaginga, J. J., Roep, B. O., & Nikolić, T. (2024) · Cells · doi:10.3390/cells13110941 · Cited by 53
Presser, D., Sester, U., Mohrbach, J., Janssen, M., Köhler, H., & Sester, M. (2009) · Kidney International · doi:10.1038/ki.2009.198 · Cited by 55
Long-Term Effects of Alemtuzumab on Regulatory and Memory T-Cell Subsets in Kidney Transplantation
Macedo, C., Walters, J., Orkis, E. A., Isse, K., Elinoff, B. D., Fedorek, S., McMichael, J., Chalasani, G., Randhawa, P. S., Demetris, A. J., et al. (2012) · Transplantation · doi:10.1097/tp.0b013e318247a717 · Cited by 49
Higher expression of Bax in regulatory T cells increases vascular inflammation
Xiong, Z. (2008) · Frontiers in bioscience · doi:10.2741/3217 · Cited by 48
“Of note, although FOXP3 plays a critical role in Treg development and function, FOXP3 per se promotes Treg apoptosis(31), and Foxp3 expression in activated T cells does not necessarily lead to acquisition of suppression function(35).”
BackgroundKoll, F. J., Banek, S., Kluth, L., Köllermann, J., Bankov, K., Chun, F. K.-H., Wild, P. J., Weigert, A., & Reis, H. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03949-3 · Cited by 47
Đokić, J., Tomić, S., Marković, M., Milosavljević, P., & Čolić, M. J. (2013) · European Journal of Immunology · doi:10.1002/eji.201243010 · Cited by 47
Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis
Lewkowicz, N., Lewkowicz, P., Dzitko, K., Kur, B., Tarkowski, M., Kurnatowska, A. J., & Tchórzewski, H. (2008) · Journal of Oral Pathology and Medicine · doi:10.1111/j.1600-0714.2008.00661.x · Cited by 46
The Role of Regulatory T Cells in the Pathogenesis of Sepsis and Its Clinical Implication
Jiang, L., Yao, Y.-M., & Sheng, Z.-Y. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0080 · Cited by 48
Long, S. A., Walker, M. R., Rieck, M., James, E., Kwok, W. W., Sanda, S., Pihoker, C., Greenbaum, C., Nepom, G. T., & Buckner, J. H. (2009) · European Journal of Immunology · doi:10.1002/eji.200838819 · Cited by 46
“Persistent expression of FOXP3 is associated with regulatory function [33] while transient expression of FOXP3 is associated with activation as demonstrated by co-expression of IFN-γ [34,35].”
BackgroundGarden, O. A., Pinheiro, D., & Cunningham, F. M. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.11.003 · Cited by 57
Regulatory T-cell as orchestra leader in immunosuppression process of multiple sclerosis
Jadidi‐Niaragh, F., & Mirshafiey, A. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2010.513391 · Cited by 49
Guerri, L., Péguillet, I., Geraldo, Y., Nabti, S., Prémel, V., & Lantz, O. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202883 · Cited by 47
“With regard to Treg development, there have been reports that Foxp3 is transiently expressed in activated non-Treg T cells in humans (53), but this does not seem to be the case in mice, in”
BackgroundHepatocytes Delete Regulatory T Cells by Enclysis, a CD4+ T Cell Engulfment Process
Davies, S. P., Reynolds, G. M., Wilkinson, A. L., Li, X., Rose, R. E., Leekha, M., Liu, Y. S., Gandhi, R., Buckroyd, E., Grove, J., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.068 · Cited by 49
Shack, L. A., Buza, J., & Burgess, S. C. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0460-2 · Cited by 53
“However, although FOXP3 is currently considered as one of the most speciWc markers for naturally occurring CD4(+)CD25(+) T-regulatory cells, expression of FOXP3 is a normal consequence of CD4(+) T cell activation and is not an exclusive marker of human T-reg [51, 52 ].”
BackgroundPillai, V., & Karandikar, N. J. (2007) · Immunology Letters · doi:10.1016/j.imlet.2007.08.012 · Cited by 48
“In some studies, use of bulk cultures in suppression assays has failed to show suppressive activity in such activated cultures [24].”
BackgroundResultmiR‐133a‐3p/FOXP3 axis regulates cell proliferation and autophagy in gastric cancer
Li, J., Zhang, H., Liu, M., Xiang, Y., Li, H., Huang, F., Li, H., Dai, Z., Gu, C. J., Liao, X., et al. (2020) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29613 · Cited by 48
“FOXP3 is a recognized marker of Treg cells, and previous studies have shown that it is indispensable for the establishment and maintenance of Treg cell phenotype and function.(22,53,54) However, it has been reported to be expressed in other types of cells such as B cells and cancer cells,(24) and the function is still…”
BackgroundRegulatory T cells in autoimmune kidney diseases and transplantation
Mikami, N., & Sakaguchi, S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00733-w · Cited by 52
Correll, A., Tuettenberg, A., Becker, C., & Jonuleit, H. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01055.x · Cited by 45
Choi, Y. S., Lee, J., Lee, H. W., Chang, D.-Y., Sung, P. S., Jung, M. K., Park, J. Y., Kim, J. K., Lee, J. I., Park, H., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306213 · Cited by 48
Chang, C., Wu, S., Kang, Y.-W., Lin, K.-P., Chen, T., Medeiros, L. J., & Chang, K. (2015) · American Journal of Clinical Pathology · doi:10.1309/ajcpujgmvv6zf4gg · Cited by 49
CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis
Ziai, J. M., Gilbert, H., Foreman, O., Eastham‐Anderson, J., Chu, F., Huseni, M. A., & Kim, J. M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190158 · Cited by 55
Regulatory T Cells: An Emerging Player in Radiation-Induced Lung Injury
Guo, T., Zou, L., Ni, J., Zhou, Y., Ye, L., Yang, X., & Zhu, Z.-F. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01769 · Cited by 48
Kaur, G., Goodall, J. C., Jarvis, L. B., & Hill Gaston, J. S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.008 · Cited by 45
CD4+CD62L+ Central Memory T Cells Can Be Converted to Foxp3+ T Cells
Zhang, X., Li, X. C., Xiao, X., Sun, R., Tian, Z., & Wei, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077322 · Cited by 48
“They suggest that human CD4+CD25- T effector cells activated through TCR stimulation alone with anti-CD3 and anti-CD28 show transiently upregulated Foxp3 expression and demonstrate that this Foxp3 expression correlates with neither anergy nor suppressive function [35,41-45].”
BackgroundRaghavan, S., Cao, D., Widhe, M., Roth, K., Herrath, J., Engström, M., Roncador, G., Banham, A. H., Trollmo, C., Catrina, A. I., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.100768 · Cited by 44
“Given the widespread FOXP3 expression in synovial fluid CD4+ T cells coexpressing varying intensities of CD25, and the reported upregulation of FOXP3 after polyclonal activation of T cells in vitro,”
BackgroundLindqvist, C. A., Christiansson, L. H., Thörn, I., Mangsbo, S. M., Paul-Wetterberg, G., Sundström, C., Tötterman, T. H., Simonsson, B., Enblad, G., Frisk, P., et al. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03439.x · Cited by 52
Gertel, S., Polachek, A., Elkayam, O., & Furer, V. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103085 · Cited by 51
Human FOXP3+ Regulatory T Cells in Transplantation
Boros, P., & Bromberg, J. S. (2009) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2009.02704.x · Cited by 45
“Instead, any mode of activation, including anti-CD3 monoclonal antibody, or allogeneic or antigen-specific stimulation, lead to a phase of FOXP3 expression in every T cell (7,8).”
BackgroundGao, Y., Lin, F. F., Su, J., Gao, Z., Li, Y., Yang, J., Deng, Z., Liu, B., Tsun, A., & Li, B. (2011) · Genes and Immunity · doi:10.1038/gene.2011.77 · Cited by 48
“23 Human CDp CD2− T cells can also transiently express FOXP3 after TcR stimulation without the requirement of other extrinsic signals, but whether or not they are suppressive during this period is still under debate”
BackgroundAdalid-Peralta, L. V., Fleury, A., García-Ibarra, T. M., Hernández, M., Parkhouse, R. M. E., Crispín, J. C., Voltaire-Proaño, J., Cárdenas, G., Fragoso, G., & Sciutto, E. (2012) · Journal of Parasitology · doi:10.1645/ge-2839.1 · Cited by 44
“Tregs are reliably defined as CD4+ cells with high levels of CD25 and CD25high FoxP3 expression (Wang et al., 2007; Zhang and Zhao, 2007).”
BackgroundYang, M., Liu, Y., Mo, B., Xue, Y., Ye, C., Jiang, Y., Bi, X., Liu, M., Wu, Y., Wang, J., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.2139/ssrn.3228224 · Cited by 43
Self-citationSatou, Y., & Matsuoka, M. (2010) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.50.1 · Cited by 54
Use of Epigenetic Modification to Induce FOXP3 Expression in Naïve T Cells
Moon, C., Kim, S. H., Park, K. S., Choi, B. K., Lee, H. S., Park, J. B., Choi, G. S., Kwan, J. H., Joh, J. W., & Kim, S. J. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.02.101 · Cited by 44
Calleja, S., Cordero‐Coma, M., Rodríguez, E., Llorente, M., Franco, M., & de Morales, J. M. G. R. (2012) · Eye · doi:10.1038/eye.2011.320 · Cited by 43
“This might explain several disparate reports of Treg quantification in disease settings”
BackgroundEnvironmental influences on T regulatory cells in inflammatory bowel disease
Hardenberg, G., Steiner, T. S., & Levings, M. K. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.01.012 · Cited by 52
Domev, H., Milkov, I., Itskovitz-Eldor, J., & Dar, A. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0097 · Cited by 43
Regulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance
Sawla, P., Hossain, A., Hahn, B. H., & Singh, R. P. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.09.008 · Cited by 43
“[5, 39, 40] while other studies find no correlation between Foxp3 expression and suppressive capacity [41, 42].”
ResultCD4+ regulatory T cells in solid organ transplantation
Issa, F., & Wood, K. J. (2010) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e32834017ae · Cited by 47
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.